Serum Level and Tissue Expression of c-erbB-2 Protein in Lung Adenocarcinoma
- 1 July 1995
- Vol. 108 (1), 157-162
- https://doi.org/10.1378/chest.108.1.157
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Detection of increased amounts of the extracellular domain of the c‐erbB‐2 oncoprotein in serum during pulmonary carcinogenesis in humansInternational Journal of Cancer, 1994
- C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.Journal of Clinical Investigation, 1994
- Detection of the extracellular domain of c‐erbB‐2 oncoprotein in sera from patients with various carcinomas: Correlation with tumor markersJournal of Clinical Laboratory Analysis, 1993
- Detection of the Ligand Activity of thec-erbB-2Protein in Calf SerumJapanese Journal of Cancer Research, 1992
- Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185
erb
B2
Science, 1990
- In vitro and in vivo Release of Soluble erbB‐2 Protein from Human Carcinoma CellsJapanese Journal of Cancer Research, 1990
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985
- The use of avidin-biotin interaction in immunoenzymatic techniques.Journal of Histochemistry & Cytochemistry, 1979